Capsule Endoscopy Market Revenue to Attain USD 883.55 Mn by 2033

Published: 14 Nov 2025

Author: Precedence Research

Share :

Table of Content

1. Capsule Endoscopy Market Revenue and Trends 2025 to 2033 2. Capsule Endoscopy Market: Key Drivers & Emerging Opportunities 3. Segment Insights 4. Regional Insights 5. Capsule Endoscopy Market Coverage 6. Capsule Endoscopy Market Key Players

Capsule Endoscopy Market Revenue and Trends 2025 to 2033

The global capsule endoscopy market revenue reached USD 479.13 million in 2025 and is predicted to attain around USD 883.55 million by 2033 with a CAGR of 7.95%. The market growth is driven by the rising prevalence of GI diseases like Crohn's and cancer, increasing patient preference for non-invasive procedures, significant advancements in capsule technology, and supportive healthcare policies and infrastructure.

Capsule Endoscopy Market: Key Drivers & Emerging Opportunities

The capsule endoscopy market involves the use of miniature, swallowable camera-equipped capsules designed to diagnose gastrointestinal disorders by capturing images of the digestive tract. The growth of this market is driven by the increasing prevalence of conditions such as small intestine tumors and colorectal cancer, which heightens the demand for effective diagnostic tools like capsule endoscopy. Additionally, there is a growing preference among patients and healthcare professionals for minimally invasive procedures, along with heightened awareness of the importance of early detection, which also contributes to the rising demand for these diagnostic tools. Furthermore, expanding healthcare infrastructure and increased investments are making advanced diagnostic technologies more accessible.

Segment Insights

• By product type, the small bowel segment dominated the market, addressing a critical clinical need: a non-invasive method to visualize the small intestine, an area that is difficult to access using conventional endoscopies.
• By application, the segment focusing on diagnosing gastrointestinal (GI) bleeding is the market leader, as capsule endoscopy is the preferred, non-invasive first-line tool for identifying the source of obscure GI bleeding, particularly in the small bowel.
• By end-user, hospitals represented the largest segment due to their superior infrastructure, higher patient influx, increased government and insurance reimbursement for these minimally invasive procedures, and advanced diagnostic capabilities.
• By component, the hardware segment, which includes the capsule and sensors, leads the market as it facilitates the core function of the device: non-invasive, real-time imaging and data capture of the digestive tract, offering a wider view and higher diagnostic yield.

Regional Insights

North America led the capsule endoscopy market, primarily due to its advanced healthcare infrastructure, high demand for minimally invasive procedures, and a significant prevalence of GI disorders. These factors drive the adoption of technologically advanced capsule endoscopy systems. A supportive regulatory environment, particularly in the U.S., also allows for timely approvals and market entry for innovative products, such as the AnX Robotics NaviCam SB capsule.

Asia Pacific region is projected to be the fastest-growing market segment due to its large population, rising incidence of gastrointestinal diseases, improving healthcare infrastructure, and increasing healthcare spending. Countries with sizable populations, such as China and India, have a significant number of patients suffering from gastrointestinal disorders, creating a large patient pool for capsule endoscopy and a growing preference for minimally invasive diagnostic tools.

Capsule Endoscopy Market Coverage

Capsule Endoscopy Market Key Players

• Medtronic plc
• Olympus Corporation
• IntroMedic Co., Ltd.
• CapsoVision, Inc.
• Given Imaging (acquired by Medtronic)
• Chongqing Jinshan Science & Technology
• RF Co., Ltd.
• SmartPill (Medtronic) 
• Yoqneam Ltd.
• Ankon Technologies Co., Ltd.
• Intromedic USA, Inc.
• Medivators (Cantel Medical)
• Check-Cap Ltd.
• EndoChoice, Inc.
• Preventice Solutions, Inc.
• Shenzhen Jinshan Science & Technology
• i-SCAN (Pentax Medical)

Recent Development

• In January 2025, CapsoVision announced that its flagship product, CapsoCam Plus®, received FDA clearance for use in pediatric patients aged two and older. This milestone allows children to benefit from the accuracy and convenience of capsule endoscopy, providing a non-invasive diagnostic option that reduces the stress often associated with traditional procedures while enhancing clinical accuracy and diagnostic confidence.
  https://www.prnewswire.com

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6889

You can place an order or ask any questions. Please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344